5414x

: £12.9 million (+27.4%), supported by synthetic biology.

: Completed a programme resulting in an approximately 5% reduction in workforce to reallocate capital to growth areas. : £12

The full regulatory document can be accessed through the London Stock Exchange or financial news platforms like ADVFN . Interim results for the 6 months ended 30 June 25 : £12.9 million (+27.4%)

"5414X" is the RNS (Regulatory News Service) identifier for the released by Oxford Nanopore Technologies plc . : £12